Loading…
Timezone
Back To Schedule
Tuesday, June 21 • 9:00am - 10:00am
#204: Diversity and Inclusion in Clinical Trials: Concrete Strategies for Enhancing Health Equity

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-22-542-L04-P ; CME 1.00; RN 1.00

The session will focus on initiatives to enhance diversity and inclusion in clinical trials. Our panel of experts will discuss concrete strategies for achieving diversity and inclusion through community engagement, training, and educational campaigns

Learning Objectives

Discuss the importance of enhancing diversity and inclusion in clinical studies; Identify concrete strategies to achieve these goals through community partnerships, trialist training, and other proactive initiatives; Evaluate various strategies and initiatives for facilitating diverse participation in clinical trials.

Chair

James Lindsay Cobbs, RPh

Speaker

Panelist
Susan C. Winckler, JD, RPh

Panelist
Lola Fashoyin-Aje, DrMed, MPH

Panelist
Sanjeeve Bala, MD

Panelist
Tesheia H. Johnson, MBA, MPH


Speakers
SB

Sanjeeve Bala

Vice President, NALA Regulatory Affairs, BeiGene, United States
JL

James Lindsay Cobbs

NALA Regulatory Affairs Policy Head, BeiGene, Inc., United States
Lindsay is currently the Regulatory Policy Head, NALA Regulatory Policy & Intelligence at BeiGene. BeiGene, founded in 2010, is a biotechnology company that specializes in the development of cancer treatments. As the NALA Policy Head, Lindsay leads a team responsible for analyzing... Read More →
LF

Lola Fashoyin-Aje

Associate Director, Science and Policy to Address Disparities, OCE, FDA, United States
Lola Fashoyin-Aje is a medical oncologist and Deputy Director in the Division of Oncology 3 in the Office of Oncologic Diseases at CDER/FDA. She provides scientific and policy guidance and oversight for the review of drugs under development for the treatment of solid tumor malignancies... Read More →
TJ

Tesheia Johnson

Deputy Director and Chief Operating Officer YCCI; Director for Clinical Research, Yale University School of Medicine, United States
avatar for Susan Winckler

Susan Winckler

Chief Executive Officer, Reagan-Udall Foundation, United States
Prior to accepting the post at the FDA’s Foundation in May of 2020, she served as President of Leavitt Partners Solutions. She advised corporate executives on policy and business matters. As CEO of the Food & Drug Law Institute, she provided attorneys, regulators, industry leaders... Read More →
avatar for Susan Winckler

Susan Winckler

Chief Executive Officer, Reagan-Udall Foundation, United States
Prior to accepting the post at the FDA’s Foundation in May of 2020, she served as President of Leavitt Partners Solutions. She advised corporate executives on policy and business matters. As CEO of the Food & Drug Law Institute, she provided attorneys, regulators, industry leaders... Read More →

Tuesday June 21, 2022 9:00am - 10:00am CDT
Room 179 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  02: ClinTrials -ClinOps, Forum |   05: Patient Engagement, Forum |   12: Value-Access, Forum